Please enable JavaScript to continue using this application.

Compare $IMDX vs $VXRT | Chartloom

Compare

$IMDX vs $VXRT

Insight Molecular Diagnostics Inc · Vaxart Inc

IMDX

Insight Molecular Diagnostics Inc

VXRT

Vaxart Inc

Compare $IMDX vs $VXRT

Comparing Insight Molecular Diagnostics Inc and Vaxart Inc

IMDXInsight Molecular Diagnostics Inc

VXRTVaxart Inc

IMDXInsight Molecular Diagnostics Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

58.81x

Rev growth (TTM)

-60.8%

YTD performance

-52.9%

52W performance

-8.4%

FCF yield

-28.4%

VXRTVaxart Inc

Market cap

$105M

P/E (TTM)

2.73x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

201.1%

YTD performance

19.2%

52W performance

26.5%

FCF yield

31.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMDX

VXRT

Detailed metrics comparison

IMDX

Insight Molecular Diagnostics Inc

VXRT

Vaxart Inc

Market Cap

IMDX$109M

VXRT$105M

Enterprise Value

IMDX$92M

VXRT$62M

Price

IMDX$3.37

VXRT$0.43

P/E Ratio

IMDXN/A

VXRT2.73x

P/S Ratio

IMDX65.16x

VXRT0.43x

EV/Sales

IMDX54.99x

VXRT0.25x

EV/EBITDA

IMDX0.00x

VXRT1.01x

P/B Ratio

IMDX102.52x

VXRT1.27x

P/FCF Ratio

IMDXN/A

VXRT3.15x

EV/FCF

IMDX-2.97x

VXRT1.85x

PEG Ratio

IMDXN/A

VXRTN/A

Forward P/E (NTM)

IMDXN/A

VXRTN/A

Forward P/S (NTM)

IMDX58.81x

VXRTN/A

Revenue (TTM)

IMDX$2M

VXRT$243M

Revenue Growth (YoY)

IMDX-60.8%

VXRT201.1%

Forward Rev Growth

IMDX593.7%

VXRT-98.8%

Gross Margin (TTM)

IMDX48.3%

VXRT100.0%

Operating Margin (TTM)

IMDX0.0%

VXRT16.3%

EBITDA Margin (TTM)

IMDX-1986.2%

VXRT18.8%

Net Margin (TTM)

IMDX-2955.6%

VXRT15.9%

FCF Margin (TTM)

IMDX-1848.8%

VXRT13.7%

Net Income (TTM)

IMDX$-49M

VXRT$39M

FCF (TTM)

IMDX$-31M

VXRT$33M

EPS (TTM)

IMDX-$1.34

VXRT$0.16

ROE (TTM)

IMDX-42668.0%

VXRT53.0%

ROA (TTM)

IMDX-14147.0%

VXRT20.8%

ROIC (TTM)

IMDX-37415.0%

VXRT50.2%

Cash

IMDX$18M

VXRT$48M

Debt

IMDX$766K

VXRT$5M

Net Cash/Debt

IMDX$17M

VXRT$43M

Current Ratio (TTM)

IMDX2.00x

VXRT1.60x

Quick Ratio (TTM)

IMDX1.82x

VXRT1.52x

Debt/Equity (TTM)

IMDX0.92x

VXRT0.06x

Debt/Assets (TTM)

IMDX0.0%

VXRT0.0%

Interest Coverage (TTM)

IMDXN/A

VXRTN/A

Net Debt/EBITDA (TTM)

IMDX0.00x

VXRT0.00x

Beta

IMDX1.86

VXRT1.23

52W Performance

IMDX-8.4%

VXRT26.5%

YTD Performance

IMDX-52.9%

VXRT19.2%

% from 52W High

IMDX-60.4%

VXRT-48.6%

% from 52W Low

IMDX39.3%

VXRT42.4%

Asset Turnover (TTM)

IMDX0.05x

VXRT1.31x

FCF Yield (TTM)

IMDX-28.4%

VXRT31.8%

Earnings Yield (TTM)

IMDX-45.4%

VXRT36.7%

Dividend Yield (TTM)

IMDXN/A

VXRTN/A

Rule of 40

IMDX-1,909.6

VXRT214.8

EV/GP/RG

IMDX10.54

VXRTN/A

Ticker research

View IMDX research View VXRT research

Metric	IMDX Insight Molecular Diagnostics Inc	VXRT Vaxart Inc
Market & Valuation
Market Cap	$109M	$105M
Enterprise Value	$92M	$62M
Price	$3.37	$0.43
P/E Ratio	N/A	2.73x
P/S Ratio	65.16x	0.43x
EV/Sales	54.99x	0.25x
EV/EBITDA	0.00x	1.01x
P/B Ratio	102.52x	1.27x
P/FCF Ratio	N/A	3.15x
EV/FCF	-2.97x	1.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	58.81x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$243M
Revenue Growth (YoY)	-60.8%	201.1%
Forward Rev Growth	593.7%	-98.8%
Profitability
Gross Margin (TTM)	48.3%	100.0%
Operating Margin (TTM)	0.0%	16.3%
EBITDA Margin (TTM)	-1986.2%	18.8%
Net Margin (TTM)	-2955.6%	15.9%
FCF Margin (TTM)	-1848.8%	13.7%
Net Income (TTM)	$-49M	$39M
FCF (TTM)	$-31M	$33M
EPS (TTM)	-$1.34	$0.16
ROE (TTM)	-42668.0%	53.0%
ROA (TTM)	-14147.0%	20.8%
ROIC (TTM)	-37415.0%	50.2%
Financial Health
Cash	$18M	$48M
Debt	$766K	$5M
Net Cash/Debt	$17M	$43M
Current Ratio (TTM)	2.00x	1.60x
Quick Ratio (TTM)	1.82x	1.52x
Debt/Equity (TTM)	0.92x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.86	1.23
52W Performance	-8.4%	26.5%
YTD Performance	-52.9%	19.2%
% from 52W High	-60.4%	-48.6%
% from 52W Low	39.3%	42.4%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.31x
FCF Yield (TTM)	-28.4%	31.8%
Earnings Yield (TTM)	-45.4%	36.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,909.6	214.8
EV/GP/RG	10.54	N/A
Ticker research	View IMDX research	View VXRT research

Valuation

P/E Ratio

VXRT

2.73x

P/S Ratio

VXRT

0.43x

IMDX

65.16x

EV/FCF

IMDX

-2.97x

VXRT

1.85x

Growth & revenue

Revenue Growth TTM

VXRT

201.1%

IMDX

-60.8%

Forward Revenue Growth

IMDX

593.7%

VXRT

-98.8%

Profitability & performance

Gross Margin

VXRT

100.0%

IMDX

48.3%

ROE

VXRT

53.0%

IMDX

-42668.0%

FCF Yield %

VXRT

31.8%

IMDX

-28.4%

52-Week Performance

VXRT

26.5%

IMDX

-8.4%

Detailed metrics comparison

IMDX

Insight Molecular Diagnostics Inc

VXRT

Vaxart Inc

Market Cap

IMDX$109M

VXRT$105M

Enterprise Value

IMDX$92M

VXRT$62M

Price

IMDX$3.37

VXRT$0.43

P/E Ratio

IMDXN/A

VXRT2.73x

P/S Ratio

IMDX65.16x

VXRT0.43x

EV/Sales

IMDX54.99x

VXRT0.25x

EV/EBITDA

IMDX0.00x

VXRT1.01x

P/B Ratio

IMDX102.52x

VXRT1.27x

P/FCF Ratio

IMDXN/A

VXRT3.15x

EV/FCF

IMDX-2.97x

VXRT1.85x

PEG Ratio

IMDXN/A

VXRTN/A

Forward P/E (NTM)

IMDXN/A

VXRTN/A

Forward P/S (NTM)

IMDX58.81x

VXRTN/A

Revenue (TTM)

IMDX$2M

VXRT$243M

Revenue Growth (YoY)

IMDX-60.8%

VXRT201.1%

Forward Rev Growth

IMDX593.7%

VXRT-98.8%

Gross Margin (TTM)

IMDX48.3%

VXRT100.0%

Operating Margin (TTM)

IMDX0.0%

VXRT16.3%

EBITDA Margin (TTM)

IMDX-1986.2%

VXRT18.8%

Net Margin (TTM)

IMDX-2955.6%

VXRT15.9%

FCF Margin (TTM)

IMDX-1848.8%

VXRT13.7%

Net Income (TTM)

IMDX$-49M

VXRT$39M

FCF (TTM)

IMDX$-31M

VXRT$33M

EPS (TTM)

IMDX-$1.34

VXRT$0.16

ROE (TTM)

IMDX-42668.0%

VXRT53.0%

ROA (TTM)

IMDX-14147.0%

VXRT20.8%

ROIC (TTM)

IMDX-37415.0%

VXRT50.2%

Cash

IMDX$18M

VXRT$48M

Debt

IMDX$766K

VXRT$5M

Net Cash/Debt

IMDX$17M

VXRT$43M

Current Ratio (TTM)

IMDX2.00x

VXRT1.60x

Quick Ratio (TTM)

IMDX1.82x

VXRT1.52x

Debt/Equity (TTM)

IMDX0.92x

VXRT0.06x

Debt/Assets (TTM)

IMDX0.0%

VXRT0.0%

Interest Coverage (TTM)

IMDXN/A

VXRTN/A

Net Debt/EBITDA (TTM)

IMDX0.00x

VXRT0.00x

Beta

IMDX1.86

VXRT1.23

52W Performance

IMDX-8.4%

VXRT26.5%

YTD Performance

IMDX-52.9%

VXRT19.2%

% from 52W High

IMDX-60.4%

VXRT-48.6%

% from 52W Low

IMDX39.3%

VXRT42.4%

Asset Turnover (TTM)

IMDX0.05x

VXRT1.31x

FCF Yield (TTM)

IMDX-28.4%

VXRT31.8%

Earnings Yield (TTM)

IMDX-45.4%

VXRT36.7%

Dividend Yield (TTM)

IMDXN/A

VXRTN/A

Rule of 40

IMDX-1,909.6

VXRT214.8

EV/GP/RG

IMDX10.54

VXRTN/A

Ticker research

View IMDX research View VXRT research

Metric	IMDX Insight Molecular Diagnostics Inc	VXRT Vaxart Inc
Market & Valuation
Market Cap	$109M	$105M
Enterprise Value	$92M	$62M
Price	$3.37	$0.43
P/E Ratio	N/A	2.73x
P/S Ratio	65.16x	0.43x
EV/Sales	54.99x	0.25x
EV/EBITDA	0.00x	1.01x
P/B Ratio	102.52x	1.27x
P/FCF Ratio	N/A	3.15x
EV/FCF	-2.97x	1.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	58.81x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$243M
Revenue Growth (YoY)	-60.8%	201.1%
Forward Rev Growth	593.7%	-98.8%
Profitability
Gross Margin (TTM)	48.3%	100.0%
Operating Margin (TTM)	0.0%	16.3%
EBITDA Margin (TTM)	-1986.2%	18.8%
Net Margin (TTM)	-2955.6%	15.9%
FCF Margin (TTM)	-1848.8%	13.7%
Net Income (TTM)	$-49M	$39M
FCF (TTM)	$-31M	$33M
EPS (TTM)	-$1.34	$0.16
ROE (TTM)	-42668.0%	53.0%
ROA (TTM)	-14147.0%	20.8%
ROIC (TTM)	-37415.0%	50.2%
Financial Health
Cash	$18M	$48M
Debt	$766K	$5M
Net Cash/Debt	$17M	$43M
Current Ratio (TTM)	2.00x	1.60x
Quick Ratio (TTM)	1.82x	1.52x
Debt/Equity (TTM)	0.92x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.86	1.23
52W Performance	-8.4%	26.5%
YTD Performance	-52.9%	19.2%
% from 52W High	-60.4%	-48.6%
% from 52W Low	39.3%	42.4%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.31x
FCF Yield (TTM)	-28.4%	31.8%
Earnings Yield (TTM)	-45.4%	36.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,909.6	214.8
EV/GP/RG	10.54	N/A
Ticker research	View IMDX research	View VXRT research